Anti-SLAMF7 / CS1 (PDL241)

Anti-SLAMF7 / CS1 (PDL241) is a novel humanized monoclonal antibody, targeting CD319. It is a promising therapeutic target for rheumatoid arthritis. MW :144.92 KD.

Trivial name PDL241
Catalog Number A3062
Size 1mg